Clinical Benefit Rate
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB14776 | Camrelizumab | 2 | Completed | 1 |
| DB14765 | Rivoceranib | 2 | Completed | 1 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB14776 | Camrelizumab | 2 | Completed | 1 |
| DB14765 | Rivoceranib | 2 | Completed | 1 |